Collectionner le produit
Détails du produit
Source
Monoclonal Anti-Hendra virus F glycoprotein Antibody, Human IgG1 (1A7) is a recombinant chimeric monoclonal antibody expressed in HEK293, which combines the variable region of a mouse monoclonal antibody with human constant domain.
Antibody Type
Recombinant Monoclonal
Clone
1A7
Isotype
Human IgG1, Kappa
Host Species
Mouse
Reactivity
Hendra virus
Immunogen
Recombinan Hendra virus Pre-Fusion glycoprotein (A263T) is expressed from human HEK293 cells
Specificity
Specifically recognizes Hendra virus Pre-Fusion glycoprotein (A263T).
Application
ApplicationRecommended UsageWestern Blot10-5 ug/mLELISA0.2-2 μg/mLPurification
Protein A purified / Protein G purified.
Aggregation
Less than 10%, as determined by SEC-MALS.
Concentration
Please refer to the Certificate of Analysis (CoA).
Form
Lyophilized
Formulation
Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.
Please contact us for customized product forms or formulations.
Reconstitution
Please refer to the Certificate of Analysis (CoA) for specific instructions.
Shipping
Lyophilized product is shipped at ambient temperature.
Storage
For long term storage, the product should be stored in a lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
Les clients ont également consulté
Affichage des données
Bioactivity-ELISA
Immobilized Hendra virus Pre-Fusion glycoprotein (A263T), His Tag (Cat. No. FUN-H52H4) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Hendra virus F glycoprotein Antibody, Human IgG1 (1A7) (Cat. No. FUN-MY2097) with a linear range of 0.6-9.8 ng/mL (QC tested).
Protocol
Western Blot
Western blot analysis of Hendra virus Pre-Fusion glycoprotein (A263T), His Tag (Cat. No. FUN-H52H4). The protein was loaded at 400 ng per lane and detected using Monoclonal Anti-Fusion glycoprotein (HeV) Antibody, Human IgG1 (1A7) at 5 μg/mL, followed by HRP-conjugated Goat Anti-Human IgG, Fcγ fragment specific secondary antibody at a 1:2000 dilution. A specific band was detected at approximately 65 kDa.
Avis des utilisateurs Publier un commentaire
Introduction de fond
Progrès de frontière
Progrès du développement médicamenteux- Nom anglais：
Respiratory syncytial virus F protein
- Catégorie：
- Nombre de médicaments répertoriés：
3 Détails
- Nombre de médicaments cliniques：
7 Détails
- Étape de développement la plus élevée：
Approved
Contact Us
Drug Candidate Licensing
